首页> 外国专利> PHARMACEUTICAL COMPOSITIONS COMPRISING IMIQUIMOD FOR USE IN THE TREATMENT OF CARCINOMA IN SITU OF THE BLADDER

PHARMACEUTICAL COMPOSITIONS COMPRISING IMIQUIMOD FOR USE IN THE TREATMENT OF CARCINOMA IN SITU OF THE BLADDER

机译:包含咪喹莫特的药物组合物,用于膀胱原位癌的治疗

摘要

The present invention relates to the field of cancer treatment, in particular to the treatment of carcinoma in situ bladder cancer and the provision of pharmaceutical compositions for use in the treatment thereof. The pharmaceutical compositions of the present invention comprise imiquimod, at least one pharmaceutically acceptable excipient, at least one organic acid and at least one thermo-sensitive agent. The present invention further relates to methods of treatment for carcinoma in situ bladder cancer and methods of administering the inventive pharmaceutical composition.
机译:本发明涉及癌症治疗领域,尤其涉及原位癌的治疗以及用于治疗的药物组合物的提供。本发明的药物组合物包含咪喹莫特,至少一种药学上可接受的赋形剂,至少一种有机酸和至少一种热敏剂。本发明进一步涉及原位癌的治疗方法和本发明药物组合物的给药方法。

著录项

  • 公开/公告号US2016331743A1

    专利类型

  • 公开/公告日2016-11-17

    原文格式PDF

  • 申请/专利权人 UROGEN PHARMA LTD;

    申请/专利号US201515110893

  • 申请日2015-01-08

  • 分类号A61K31/4745;A61K9;A61K47/12;A61K47/02;A61K47/10;A61K47/36;

  • 国家 US

  • 入库时间 2022-08-21 13:49:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号